GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
-8.5%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$145M
AUM Growth
+$145M
Cap. Flow
-$34.6M
Cap. Flow %
-23.79%
Top 10 Hldgs %
57.57%
Holding
46
New
5
Increased
10
Reduced
10
Closed
15
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NMTR
26
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
$469K 0.24%
1,800,000
-1,450,000
-45% -$378K
SYRE icon
27
Spyre Therapeutics
SYRE
$1.02B
$467K 0.24%
925,000
+238,401
+35% +$120K
DICE
28
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$466K 0.24%
+30,000
New +$466K
ALNY icon
29
Alnylam Pharmaceuticals
ALNY
$58.6B
$277K 0.14%
+1,900
New +$277K
SRRA
30
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-325,000
Closed -$10.4M
STSA
31
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-473,562
Closed -$1.8M
PRDS
32
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
-85,000
Closed -$614K
ZNTL icon
33
Zentalis Pharmaceuticals
ZNTL
$123M
-80,000
Closed -$3.69M
XENE icon
34
Xenon Pharmaceuticals
XENE
$2.99B
-100,000
Closed -$3.06M
XBI icon
35
SPDR S&P Biotech ETF
XBI
$5.29B
0
VTGN icon
36
VistaGen Therapeutics
VTGN
$113M
-1,315,154
Closed -$1.63M
RCKT icon
37
Rocket Pharmaceuticals
RCKT
$358M
-200,000
Closed -$3.17M
PYXS icon
38
Pyxis Oncology
PYXS
$91.2M
-75,000
Closed -$303K
LRMR icon
39
Larimar Therapeutics
LRMR
$337M
-100,000
Closed -$405K
LPTX icon
40
Leap Therapeutics
LPTX
$12M
-993,714
Closed -$1.74M
CRNX icon
41
Crinetics Pharmaceuticals
CRNX
$3.26B
-85,000
Closed -$1.87M
CLDX icon
42
Celldex Therapeutics
CLDX
$1.57B
-300,000
Closed -$10.2M
BCYC
43
Bicycle Therapeutics
BCYC
$492M
-100,000
Closed -$4.39M
ACRS icon
44
Aclaris Therapeutics
ACRS
$223M
-125,000
Closed -$2.16M
SPY icon
45
SPDR S&P 500 ETF Trust
SPY
$656B
0
VRNA
46
Verona Pharma
VRNA
$9.18B
-750,000
Closed -$3.74M